1. Home
  2. AGCC vs XOMA Comparison

AGCC vs XOMA Comparison

Compare AGCC & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGCC

Agencia Comercial Spirits Ltd Class A Ordinary Shares

N/A

Current Price

$18.87

Market Cap

298.5M

ML Signal

N/A

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$39.71

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCC
XOMA
Founded
2020
1981
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
298.5M
308.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AGCC
XOMA
Price
$18.87
$39.71
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$60.60
AVG Volume (30 Days)
245.0K
121.1K
Earning Date
05-23-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.59
Revenue Next Year
N/A
N/A
P/E Ratio
$168.97
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$4.23
$20.95
52 Week High
$24.98
$40.70

Technical Indicators

Market Signals
Indicator
AGCC
XOMA
Relative Strength Index (RSI) 63.72 84.14
Support Level $13.47 $24.38
Resistance Level $18.11 N/A
Average True Range (ATR) 1.17 1.66
MACD 0.01 0.54
Stochastic Oscillator 95.16 90.75

Price Performance

Historical Comparison
AGCC
XOMA

About AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares

Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: